References
- Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e0003832.
- World Health Organization. WHO prequalified vaccines [Internet]. WHO Prequalified Vaccines All Vaccines Present. 2018. p. 5. [cited 2018 Mar 3]. Available from: https://extranet.who.int/gavi/PQ_Web/?AspxAutoDetectCookieSupport=1
- Desai SN, Pezzoli L, Alberti KP, et al. Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era. Hum Vaccines Immunother [Internet]. 2017;13:579–587.
- Saha A, Khan A, Salma U, et al. The oral cholera vaccine shanchol when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants. Vaccine. 2016;34:1551–1558.
- Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1694–1702.
- Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis [Internet]. 2013;13:1050–1056. cited 2017 Jun 12. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1473309913702731
- Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. Ryan ET, editor. PLoS Negl Trop Dis [Internet]. 2011;5:e1289.
- Mahalanabis D, Lopez AL, Sur D, et al. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One. 2008;3(6):e2323. doi: 10.1371/journal.pone.0002323.
- Kanungo S, Desai SN, Saha J, et al. An open label non-inferiority trial assessing vibriocidal response of a killed bivalent oral cholera vaccine regimen following a five year interval in Kolkata, India. PLoS Negl Trop Dis. 2015;9:1–13.
- Sen GS, Bharati K, Sur D, et al. Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons. Indian J Med Res [Internet]. 2016;143:545–551. [cited 2017 Nov 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27487997
- Hsiao A, Desai SN, Mogasale V, et al. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. Bull World Health Organ [Internet]. 2017;95:303–312. Available from: http://www.who.int/entity/bulletin/volumes/95/4/16-175166.pdf
- Sur D. Global deployment of oral cholera vaccine (OCV). In 5th Meet. IDEA Asia [Internet]; Hanoi, Vietnam: Initiative against Diarrheal and Enteric diseases in Africa and Asia; 2017. p. 20. [cited 2018 Mar 3]. Available from: http://www.cholera-network.org/wp-content/uploads/2017/05/dipika-sur.pdf
- GAVI. 900,000 vaccines “en route” to cox’s bazar to prevent cholera - gavi, the vaccine alliance. Press Release [Internet]. 2017;3. [cited 2018 Mar 3]. Available from: http://www.gavi.org/library/news/press-releases/2017/900000-vaccines-en-route-to-coxs-bazar-to-prevent-cholera/
- Ferreras E, Chizema-Kawesha E, Blake A, et al. Single-dose cholera vaccine in response to an outbreak in Zambia. N Engl J Med [Internet]. 2018;378:577–579.
- Azman AS, Parker LA, Rumunu J, et al. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study. Lancet Glob Heal [Internet]. 2016;4:e856–e863. [cited 2017 May 13]. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2214109X1630211X
- Qadri F, Wierzba TF, Ali M, et al. Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh. N Engl J Med [Internet]. 2016;374:1723. [cited 2017 May 13]. Available from .
- Kanungo S, Paisley A, Lopez AL, et al. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial. Vaccine. 2009;27:6887–6893.
- Lopez AL, Deen J, Azman AS, et al. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis. Clin Infect Dis [Internet]. 2017 [cited 2018 Mar 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29177437
- Azman AS, Luquero FJ, Ciglenecki I, et al. The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study. kretzschmar MEE, editor. PLOS Med [Internet]. 2015;12:e1001867. [cited 2017 May 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26305226
- Weill F-X, Domman D, Njamkepo E, et al. Genomic history of the seventh pandemic of cholera in Africa. Science [Internet]. 2017;358:785–789. [cited 2018 Mar 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29123067
- Ali M, Sen Gupta S, Arora N, et al. Identification of burden hotspots and risk factors for cholera in India: an observational study. PLoS One [Internet]. 2017;12:e0183100. [cited 2018 Mar 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28837645
- Bwire G, Ali M, Sack DA, et al. Identifying cholera “hotspots” in Uganda: an analysis of cholera surveillance data from 2011 to 2016. Ivers LC, editor. PLoS Negl Trop Dis [Internet]. 2017;11:e0006118.
- Anbarci N, Escaleras M, Register CA. From cholera outbreaks to pandemics: the role of poverty and inequality. Am Econ [Internet]. 2012;57:21–31.
- Kar SK, Sah B, Patnaik B, et al. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the odisha model. PLoS Negl Trop Dis. 2014;8:e2629.
- Abubakar A, Azman AS, Rumunu J, et al. The first use of the global oral cholera vaccine emergency stockpile: lessons from South Sudan. PLOS Med [Internet]. 2015;12:e1001901. cited 2018 Mar 3.
- Lam E, Al-Tamimi W, Russell SP, et al. Oral cholera vaccine coverage during an outbreak and humanitarian crisis, Iraq, 2015. Emerg Infect Dis Internet. 2017;23:38–45. [cited 2018 Mar 3]. Available from: http://wwwnc.cdc.gov/eid/article/23/1/16-0881_article.htm
- Tohme RA, François J, Wannemuehler K, et al. Oral cholera vaccine coverage, barriers to vaccination, and adverse events following vaccination, haiti, 2013. Emerg Infect Dis [Internet]. 2015;21:984–991. [cited 2018 Mar 3]. Available from: http://wwwnc.cdc.gov/eid/article/21/6/14-1797_article.htm
- Longini IM, Nizam A, Ali M, et al. Controlling endemic cholera with oral vaccines. von Seidlein L, editor. PLoS Med [Internet]. 2007;4:e336. [cited 2017 Jun 12]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18044983
- World Health Organization, editor. Resolution WHA67.20. regulatory system strengthening for medical products. WHA67/2014/REC/1. In: Sixty-seventh World Heal. Assem., Geneva, 19–24 May 2014. Resolut. Decis. Annex [Internet]. 1st ed. Geneva: World Health Organization; 2014. p. 41. [cited 2018 Mar 3]. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf#page=1
- Wadman M. Cholera vaccination campaign in Yemen is dropped. Sci (80-.) [Internet]. 2017. [cited 2018 Mar 3]. Available from: http://www.sciencemag.org/news/2017/07/cholera-vaccination-campaign-yemen-dropped
- Ciglenecki I, Sakoba K, Luquero FJ, et al. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med [Internet]. 2013;10:e1001512.
- Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015;386:1362–1371.
- Null C, Stewart CP, Pickering AJ, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial. Lancet Glob Heal [Internet]. 2018;6:e316–e329. [cited 2018 Mar 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29396219
- Luby SP, Rahman M, Arnold BF, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Bangladesh: a cluster randomised controlled trial. Lancet Global Health [Internet]. 2018;6:e302–e315. [cited 2018 Mar 3]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29396217
- Kanungo S, Desai SN, Nandy RK, et al. Flexibility of oral cholera vaccine dosing— a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone. PLoS Negl Trop Dis. 2015;9:e0003574.